Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory Gene Freitag currently holds 54,876 shares of ZyVersa Therapeutics, Inc. (ZVSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Gene Freitag has been a net seller of ZVSA stock. They have purchased $153.7K and sold $4.1M worth of shares.
Gregory Gene Freitag's most recent insider trade was on Jan 12, 2026, when they sold 54,876 shares at $0.00 per share.
Gregory Gene Freitag serves as Executive at ZyVersa Therapeutics, Inc. (ZVSA). They have executed 74 insider transactions totaling $4.3M over their tenure at the company.
Gregory Gene Freitag holds the position of Executive at ZyVersa Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Gregory Gene Freitag has shown a selling trading pattern, with $153.7K in total purchases and $4.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gregory Gene Freitag was on Nov 30, 2018, when they sold $1.5M worth of AXGN shares. This transaction involved 45,000 shares at $33.00 per share.
Gregory Gene Freitag currently owns 54,876 shares of ZyVersa Therapeutics, Inc. (ZVSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory Gene Freitag's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory Gene Freitag has 74 Form 4 filings on record as an insider at ZyVersa Therapeutics, Inc..
Set alerts for Gregory Gene Freitag and 40,000+ other insiders.